Reporting nuchal translucency (NT) measurements of less than 1.0 mm are acceptable in the NHS Fetal Anomaly Screening Programme (FASP).
NHS Fetal Anomaly Screening Programme
Updates from some of the early adopter sites who piloted giving out digital information about antenatal and newborn screening rather than physical leaflets at the start of the year.
PHE has published the second antenatal screening standards data report, covering 1 April 2018 to 31 March 2019.
Find out more about our new non-invasive prenatal testing (NIPT) e-learning resource.
We have published the fourth and final set of quarterly key performance indicator (KPI) data for the 2019 to 2020 year.
Directing people to digital information about NHS antenatal and newborn screening programmes should now be business as usual.
Antenatal and newborn screening providers should now be signposting parents routinely to digital versions of information leaflets rather than automatically handing out printed leaflets.
A formal procurement process for laboratories wishing to provide non-invasive prenatal testing (NIPT) has been launched for the NHS Fetal Anomaly Screening Programme (FASP).
We’ve published new guidance for screening professionals to support women with learning disabilities and their partners to access and understand antenatal and newborn (ANNB) screening.
Survey for NHS antenatal screening providers to help inform smooth transition to using digital information resources for pregnant women.